Published in Graefes Arch Clin Exp Ophthalmol on November 14, 2016
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun (1997) 3.49
LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta (2006) 3.05
Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun (2001) 1.74
Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest Ophthalmol Vis Sci (2011) 1.70
Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect (2013) 1.62
Animal use in pharmacology education and research: the changing scenario. Indian J Pharmacol (2014) 1.45
Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88. Infect Immun (2006) 1.43
The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis. Infect Immun (2000) 1.25
The corneal response to Pseudomonas aeruginosa: histopathological and enzymatic characterization. Invest Ophthalmol Vis Sci (1977) 1.18
A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol Cell Biol (2005) 1.11
Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res (2006) 1.04
The development of a tissue-engineered cornea: biomaterials and culture methods. Pediatr Res (2008) 1.04
Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model. Infect Immun (2007) 1.03
Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J (2008) 0.99
Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect Immun (2010) 0.98
Ex vivo organotypic corneal model of acute epithelial herpes simplex virus type I infection. J Vis Exp (2012) 0.97
Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother (2005) 0.94
Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes. Invest Ophthalmol Vis Sci (2007) 0.93
miR-155 suppresses bacterial clearance in Pseudomonas aeruginosa-induced keratitis by targeting Rheb. J Infect Dis (2014) 0.93
Animal models of bacterial keratitis. J Biomed Biotechnol (2011) 0.93
The three-dimensional microanatomy of the rabbit and human cornea. A chemical and mechanical microdissection-SEM approach. J Anat (2001) 0.92
Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singapore Med J (2012) 0.91
Staphylococcus corneal virulence in a new topical model of infection. Invest Ophthalmol Vis Sci (2001) 0.91
The role of twitching motility in Pseudomonas aeruginosa exit from and translocation of corneal epithelial cells. Invest Ophthalmol Vis Sci (2009) 0.91
The corneal expression of antimicrobial peptides during experimental fungal keratitis. Curr Eye Res (2010) 0.91
Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis. Antimicrob Agents Chemother (2004) 0.90
Development of a surface-modified contact lens for the transfer of cultured limbal epithelial cells to the cornea for ocular surface diseases. Tissue Eng Part A (2009) 0.88
Why does the healthy cornea resist Pseudomonas aeruginosa infection? Am J Ophthalmol (2013) 0.88
Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology. Infect Immun (2012) 0.87
Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. Invest Ophthalmol Vis Sci (2013) 0.87
Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea (1993) 0.86
Activation of focal adhesion kinase enhances the adhesion of Fusarium solani to human corneal epithelial cells via the tyrosine-specific protein kinase signaling pathway. Mol Vis (2011) 0.85
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol (2007) 0.85
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Curr Eye Res (2007) 0.85
Corneal wound healing is modulated by topical application of amniotic fluid in an ex vivo organ culture model. Exp Eye Res (2008) 0.83
In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU. Invest Ophthalmol Vis Sci (2009) 0.83
Development of a microfabricated artificial limbus with micropockets for cell delivery to the cornea. Biofabrication (2013) 0.82
Triple infection keratitis. Eye Contact Lens (2014) 0.81
In vivo confocal microscopy for the detection of canine fungal keratitis and monitoring of therapeutic response. Vet Ophthalmol (2015) 0.80
The molecular pathogenicity of Fusarium keratitis: a fungal transcriptional regulator promotes hyphal penetration of the cornea. Cornea (2010) 0.80
Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.80
The use of concanavalin A to competitively inhibit Pseudomonas aeruginosa adherence to rabbit corneal epithelium. CLAO J (1990) 0.80
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model. Curr Eye Res (2005) 0.79
Multipurpose care solution-induced corneal surface disruption and Pseudomonas aeruginosa internalization in the rabbit corneal epithelium. Invest Ophthalmol Vis Sci (2014) 0.79
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo]. Arch Soc Esp Oftalmol (2009) 0.79
Assessment of anti-scarring therapies in ex vivo organ cultured rabbit corneas. Exp Eye Res (2014) 0.79
Profile of microbial keratitis after corneal collagen cross-linking. Biomed Res Int (2014) 0.79
lukSF-PV in Staphylococcus aureus keratitis isolates and association with clinical outcome. Invest Ophthalmol Vis Sci (2013) 0.79
Reduce, refine, replace. Nat Immunol (2010) 0.78
Rocking media over ex vivo corneas improves this model and allows the study of the effect of proinflammatory cytokines on wound healing. Invest Ophthalmol Vis Sci (2015) 0.78
Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis. Cell Mol Life Sci (2014) 0.78
Animal models to investigate fungal biofilm formation. Methods Mol Biol (2014) 0.78
Development of a novel ex vivo model of corneal fungal adherence. Graefes Arch Clin Exp Ophthalmol (2010) 0.77
Experimental model of Fusarium solani keratitis in rats. Int J Ophthalmol (2011) 0.77
TLR2 activation in corneal stromal cells by Staphylococcus aureus-induced keratitis. APMIS (2014) 0.76
A Comparison of Clinical Features between Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Keratitis. J Ophthalmol (2015) 0.76
In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis. J Infect Chemother (2013) 0.76
Comparative analysis of agr groups and virulence genes among subclinical and clinical mastitis Staphylococcus aureus isolates from sheep flocks of the Northeast of Brazil. Braz J Microbiol (2013) 0.76
Fusarium keratitis at a tertiary eye care centre in India. Int Ophthalmol (2014) 0.76